ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.

David W Haas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.